N-Desmethyl Imatinib Dimesylate is a by-product of the synthesis of N-Desmethyl Imatinib Mesylate (D292345), a metabolite of Gleevec, a tyrosine kinase inhibitor which is highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemi
Molecular Weight:
479.58210816
Form:
Supplied as a Yellow Gum
* VAT and and shipping costs not included. Errors and price changes excepted